ABSTRACT
PURPOSE: The purpose of the study was to report a patient with Seckel syndrome associated with high intraocular pressures despite intensive antiglaucoma treatment. METHODS: Case report. RESULTS: High intraocular pressure readings in both eyes measured with the Goldman applanation tonometer, bilateral pigmentary retinopathy and total cupping of optic discs were found. The patient underwent bilateral trabeculectomy surgery as he had medically uncontrolled glaucoma. CONCLUSIONS: Childhood glaucoma may be associated with Seckel syndrome.
Subject(s)
Dwarfism/diagnosis , Glaucoma, Open-Angle/diagnosis , Microcephaly/diagnosis , Child , Consanguinity , Facies , Glaucoma, Open-Angle/surgery , Humans , Intraocular Pressure , Male , Tonometry, Ocular , TrabeculectomyABSTRACT
The goal of this study was to compare in vitro and in vivo efficacy of moxifloxacin and liposomal amphotericin B (Amp-B) monotherapies and combination treatment against Candida albicans in an exogenous endophthalmitis model in rabbit eyes. Microplate dilution tests and checkerboard analysis were performed to detect in vitro efficacies. Endophthalmitis was induced by intravitreal injection of C. albicans in 40 rabbit eyes with simultaneous intravitreal drug injection according to prophylactic treatment groups. Group 1 (control group) received 0.1 mL of balanced salt solution, group 2 (moxi group) 100 microg moxifloxacin/0.1 mL, group 3 (Amp-B group) 10 microg liposomal Amp-B/0.1 mL, and group 4 (combi group) both 100 microg moxifloxacin/0.1 mL [DOSAGE ERROR CORRECTED] and 10 microg liposomal Amp-B/0.05 mL intravitreally. Clinical examination, quantitative analysis of microorganisms, and histopathologic examination were performed as in vivo studies. The minimum inhibitory concentration of liposomal Amp-B against C. albicans was found to be 1 microg/mL. Moxifloxacin showed no inhibition of in vitro C. albicans growth. The minimum inhibitory concentration values of liposomal Amp-B for C. albicans were reduced two- to eightfold with increasing concentrations of moxifloxacin in vitro. In vivo, there was no C. albicans growth in the combi group (zero of eight eyes), whereas three eyes (37.5%) showed growth in the Amp-B group. Vitreous inflammation, retinal detachment, focal retinal necrosis, and outer nuclear layer loss were found to be lower in the moxi group compared with the control group. Ganglion cell and inner nuclear layer loss was observed in all eyes (100%) in both the moxi and combi groups, whereas only in 25% (two of eight eyes) in the Amp-B group. Moxifloxacin strongly augments the efficacy of liposomal Amp-B against C. albicans in vitro, although it has no in vitro antifungal activity when used alone. It is interesting that we found a synergistic effect for in vitro tests but failed to demonstrate it in vivo. When 100 microg moxifloxacin/0.1 mL is given intravitreally, it has some toxic effects that are limited to the inner retinal layers.
Subject(s)
Amphotericin B , Antifungal Agents , Aza Compounds , Candida albicans , Candidiasis , Endophthalmitis , Eye Infections, Fungal , Quinolines , Amphotericin B/pharmacology , Amphotericin B/therapeutic use , Animals , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Aza Compounds/pharmacology , Aza Compounds/therapeutic use , Candida albicans/drug effects , Candida albicans/physiology , Candidiasis/drug therapy , Candidiasis/microbiology , Candidiasis/pathology , Colony Count, Microbial , Disease Models, Animal , Drug Resistance, Fungal/drug effects , Drug Therapy, Combination , Endophthalmitis/drug therapy , Endophthalmitis/microbiology , Endophthalmitis/pathology , Eye Diseases/drug therapy , Eye Diseases/pathology , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/pathology , Eye Infections, Fungal/drug therapy , Eye Infections, Fungal/microbiology , Eye Infections, Fungal/pathology , Fluoroquinolones , Microbial Sensitivity Tests , Moxifloxacin , Quinolines/pharmacology , Quinolines/therapeutic use , Rabbits , Vitreous Body/drug effects , Vitreous Body/microbiology , Vitreous Body/pathologyABSTRACT
BACKGROUND: To investigate the effect of transpupillary thermotherapy (TTT) on choroidal neovascularization (CNV) secondary to angioid streaks. METHODS: Six eyes of 5 patients with an average age of 61 years were diagnosed to have subfoveal CNV secondary to angioid streaks. Four of the CNVs were predominantly classic and 2 were occult with no classic. Visual acuity (VA) measurement, ophthalmoscopic and fluorescein angiographic examination, and optic coherence tomography (OCT) were carried out before TTT treatment and at each follow-up visit. Activity scores (AS) based on clinical, angiographic, and OCT findings were also recorded. RESULTS: The mean follow-up was 12 months. The VA initially ranged from counting fingers to 20/100 and remained stable in all patients. The mean greatest lesion diameter increased significantly from 2221 microm to 3109 microm at last follow-up (p=0.046). The mean AS decreased significantly from 6.5 to 4.8 at the 3rd month (p=0.039), but tended to increase thereafter. Retreatment with TTT was applied to 5 eyes after a mean of 7.8 months but did not decrease CNV activity as effectively as the first treatments. A fibrotic scar developed in 1 eye after the first treatment. INTERPRETATION: TTT may decrease the activity of CNVs secondary to angioid streaks in the short term, but retreatment may be necessary with unfavorable results. TTT appears to stabilize VA but not lesion size in this group of patients, which may be the natural history rather than a treatment effect.
Subject(s)
Angioid Streaks/complications , Choroidal Neovascularization/therapy , Hyperthermia, Induced/methods , Aged , Choroidal Neovascularization/diagnosis , Choroidal Neovascularization/etiology , Female , Fluorescein Angiography , Follow-Up Studies , Humans , Male , Middle Aged , Pupil , Retreatment , Tomography, Optical Coherence , Treatment Outcome , Visual AcuityABSTRACT
PURPOSE: To evaluate the use of transpupillary thermotherapy (TTT) for myopic choroidal neovascularization (CNV) retrospectively in a case series. METHODS: Ten consecutive patients with CNV secondary to high myopia were treated with TTT and followed-up for 18.3 +/- 7.1 months (range: 12-30 months). An activity scoring (AS) scheme based on CNV size, central foveal thickness as determined by optical coherence tomography (OCT), amount of subretinal hemorrhage, and fluorescein angiography (FA) staining characteristics was developed to assess the response to treatment. The main outcome measures were AS and visual acuity (VA). RESULTS: There was no significant loss or gain in VA, and the lesions stabilized in all eyes. FA revealed late staining typical of CNV scarring, and the amount of central foveal thickness decreased in all eyes, as determined by OCT. The mean AS at 3, 6, and 12 months and at the final visit were significantly lower than the preoperative AS (P<0.05). No complication occurred during or after treatment. CONCLUSION: A scheme for evaluating overall CNV activity may be useful tool for assessing the response of patients to TTT. TTT seems to stabilize myopic CNVs both clinically and as revealed by angiography, with a significant decrease in the activity of lesions. Longer term results are required to evaluate the stabilizing effect of TTT in myopic CNV.
Subject(s)
Choroidal Neovascularization/therapy , Hyperthermia, Induced/methods , Myopia, Degenerative/complications , Adult , Aged , Aged, 80 and over , Choroidal Neovascularization/etiology , Choroidal Neovascularization/pathology , Female , Fluorescein Angiography , Follow-Up Studies , Fundus Oculi , Humans , Male , Middle Aged , Myopia, Degenerative/physiopathology , Pupil , Refraction, Ocular , Retrospective Studies , Severity of Illness Index , Time Factors , Tomography, Optical Coherence , Treatment Outcome , Visual AcuityABSTRACT
BACKGROUND: The formation of free oxygen radicals has been demonstrated in the corneal tissue after 193 nm laser irradiation. Cornea has several defense mechanisms that protect against oxidative damage. One of them, glutathione peroxidase (GPx), catalyzes the destruction of hydrogen peroxide and lipid hydroperoxide. Selenium is a trace element which is incorporated into the selenoenzyme GPx. In the present study, the effect of excimer laser keratectomy on corneal GPx activities and aqueous humor selenium concentrations in rabbits was evaluated. METHODS: Animals were divided into five groups, and all groups were compared: controls (group 1), after epithelial scraping (group 2), transepithelial photorefractive keratectomy(PRK; group 3), superficial traditional PRK (50 microm; group 4) and deep traditional PRK (100 microm; group 5). Corneal GPx activities were measured by a modification of the coupled assay procedure. Aqueous humor selenium concentrations were determined using hydride generation atomic absorption spectrometry. RESULTS: Corneal GPx activities were significantly lower only in group 5 ( P<0.05), and the selenium concentration in the aqueous humor did not change in any group. CONCLUSION: Deep corneal photoablation inhibits GPx enzyme activities in the cornea. Therefore, antioxidants may be useful in reducing free radical-mediated complications after excimer laser corneal photoablation.